Pre-seed · Enterprise software
Axio BioPharma closes $2.4M pre-seed round
Axio BioPharma closed a $2.4 million pre-seed round in September, with Elmstead Partners, Chisos Capital and Chemical Angel Network participating alongside individual angels.
The company plans initial deployments of Axio Lattice and further development of Rosetta, its ontology mapping layer.
Its first Lattice node is operating at Forward BioLabs as it prepares deployments with design partners. The financing supports collaboration between pharmaceutical companies and manufacturing partners while each organization retains its own systems and data.
Use of funds
Support initial deployments of Axio Lattice
Continue development of Rosetta ontology mapping layer
Funding history
Pre-seed · This round$2.4M